US2009023717A1PendingUtilityA1
Morphine-bridged indazole derivatives
Est. expirySep 26, 2022(expired)· nominal 20-yr term from priority
Inventors:Achim FeurerJoachim LuithleStephan-Nicholas WirtzGerhard KonigJohannes-Peter StaschFrank WunderDieter LangElke StahlThomas SchenkeRudy Schreiber
A61P 43/00A61P 25/28A61P 25/00C07D 471/04
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to novel morpholine-bridged indazole derivatives which stimulate soluble guanylate cyclase, to process for the preparation thereof, and to the use thereof for producing medicaments, in particular medicaments for the treatment of disorders of the central nervous system.
Claims
exact text as granted — not AI-modified1 . A method for the treatment of central nervous system diseases comprising administering to a human or animal an effective amount of a compound of of the formula
in which
R 1 is
where
n is 1 or 2, and
R 2 is hydrogen or NH 2 ,
or a salt, solvate, or solvate of a salt thereof.
2 . A method for the treatment of disorders of perception, concentration, learning or memory comprising administering to a human or animal an effective amount of a compound of the formula
in which
R 1 is
where
n is 1 or 2, and
R 2 is hydrogen or NH 2 ,
or a salt, solvate, or solvate of a salt thereof.Join the waitlist — get patent alerts
Track US2009023717A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.